PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
190.44%
Net income growth above 1.5x CRK's 45.06%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
6.38%
D&A growth well above CRK's 5.36%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
141.65%
Well above CRK's 30.71% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-342.49%
Negative yoy working capital usage while CRK is 201.90%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-342.49%
Negative yoy usage while CRK is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
4415.47%
Well above CRK's 66.42%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
13.29%
Operating cash flow growth below 50% of CRK's 88.97%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
20.43%
Some CapEx rise while CRK is negative at -46.28%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-57.59%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
12.58%
We have mild expansions while CRK is negative at -46.28%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
90.67%
Debt repayment growth of 90.67% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
1.06%
Lower share issuance yoy vs. CRK's 122.30%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
35.04%
Buyback growth of 35.04% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.